bluebird bio Inc (NAS:BLUE)
$ 0.405 0.0272 (7.2%) Market Cap: 78.75 Mil Enterprise Value: 376.50 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 31/100

bluebird bio Inc at Bank of America Merrill Lynch Health Care Conference Transcript

May 14, 2019 / 10:00PM GMT
Release Date Price: $82.01 (+1.77%)
Ying Huang
BofA Merrill Lynch, Research Division - Director in Equity Research

Let's get started with the next session. So my name is Ying Huang. I'm the senior biotech analyst covering large-cap biotech here at BofA Merrill Lynch. And we're very pleased to have our next presenting company bluebird bio. We have CEO -- well, actually, I should say Chief bluebird, Nick Leschly, from bluebird. And I think...

Nick Leschly
bluebird bio, Inc. - President, CEO & Director

I'm proud of you right now, and that's good.

Ying Huang
BofA Merrill Lynch, Research Division - Director in Equity Research

Thank you. Appreciate it. So, Nick will probably have a few slides and some prepared remarks and then we'll go into Q&A after that. With that, let me welcome Nick to Vegas, I remember last year we had some accident the with the air traffic situation. So I'm glad you are here in (inaudible).

Nick Leschly
bluebird bio, Inc. - President, CEO & Director

(inaudible)

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot